Log In
BCIQ
Print this Print this
 

BB2603

  Manage Alerts
Collapse Summary General Information
Company Blueberry Therapeutics Ltd.
DescriptionNanomedicine reformulation of an undisclosed antifungal agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationTinea pedis
Indication DetailsTreat tinea pedis (athlete's foot)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today